Professor Chas Bountra and Dr Javier Lezaun take a fresh look at the way we organise early-stage (high-risk/high-reward) pharmaceutical research. The drug discovery process is extremely high risk, takes too long and is becoming unaffordable. The pharmaceutical industry, despite massive investments, has been forced to reduce risk and costs. With ageing societies and the rise of chronic diseases of modern living, we desperately need better therapeutics. Professor Chas Bountra and Dr Javier Lezaun will examine alternatives to the traditional way of doing things, and propose a radical solution - arguably the only way to resolve this dilemma.